Anti-Aging Peptides: Longevity Research Guide | Quantum Labs

The peptides studied in aging research

Aging biology — sometimes called geroscience — is one of the largest expanding areas of biomedical research. The underlying premise is that aging itself is a biological process with characterisable mechanisms: cellular senescence, telomere attrition, mitochondrial decline, loss of proteostasis, deregulated nutrient sensing, stem-cell exhaustion, and altered intercellular communication. Several research peptides target specific mechanisms within this catalog, which is why “anti-aging peptides” has become a research category in its own right.

This article walks through the peptides most-cited in aging-biology research literature, what mechanisms each targets, and where the Australian research-supply pathway fits. The framing throughout is research and pre-clinical literature; questions about personal anti-aging interventions should go to a qualified medical practitioner.

Epithalon: the most-cited longevity peptide

Epithalon (also written as Epitalon — both transliterations of the same Russian-developed compound) is the most extensively studied peptide in longevity research literature. It's a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed at the St. Petersburg Institute of Bioregulation and Gerontology, where it has been the subject of decades of research in animal-aging and human-aging contexts.

The most-cited mechanism is telomerase activity. Telomeres — the protective caps at the end of chromosomes — shorten with each cell division, and the gradual accumulation of shortened telomeres is one of the hallmarks of cellular aging. Epithalon research has examined telomerase enzyme activation, telomere length maintenance, and downstream effects on cell-replicative capacity. Studies in rodent aging models have produced data on lifespan, age-related biomarker changes, and pineal-gland melatonin axis regulation.

For Australian researchers studying longevity pathways, Epithalon is the most-established research-grade compound in the category. Research-grade Epithalon is available from the Epithalon product page. The compound has a 28% AU-volume cluster of its own and is one of the longer-running entries in our catalogue.

NAD+ and cellular-energy research

NAD+ (Nicotinamide Adenine Dinucleotide, oxidised form) is one of the foundational cofactors in cellular energy biology. It's involved in electron transport, redox reactions, and serves as substrate for sirtuin and PARP enzyme families — both of which intersect heavily with aging-biology research.

The relevance to aging: tissue NAD+ levels decline with age in well-characterised research models. Multiple mechanisms contribute — increased NAD+ consumption by PARP enzymes responding to age-related DNA damage, increased CD38 activity, and reduced synthesis capacity. The age-related NAD+ decline correlates with reduced sirtuin activity, impaired mitochondrial function, and downstream effects on cellular bioenergetics. Restoring NAD+ pools is a major focus of contemporary aging research.

Research-grade NAD+ is available from the NAD+ product page for laboratory and pre-clinical research applications.

GHK-Cu: dermal-aging and broader regenerative research

GHK-Cu sits at an interesting cross-section of aging research. The compound occurs naturally in human plasma at concentrations that decline with age — from about 200 ng/mL in the third decade to roughly 80 ng/mL by the seventh. The decline itself has been a focus of aging-biology research, alongside the compound's effects on dermal collagen synthesis, wound-healing models, and the broader extracellular matrix.

Where Epithalon targets the telomere-maintenance side of cellular aging, GHK-Cu targets the dermal and connective-tissue aging side. The two compounds are complementary rather than competing — they answer different aging-biology questions through different mechanisms.

Full coverage of GHK-Cu mechanism is in our copper peptide research guide. Research-grade GHK-Cu is available from the GHK-Cu product page.

SS-31: mitochondria-targeted aging research

Mitochondrial dysfunction is one of the canonical hallmarks of aging — declining mitochondrial efficiency, accumulating mitochondrial DNA damage, and impaired mitochondrial turnover all feature in published aging-biology research. SS-31 (elamipretide) is a synthetic tetrapeptide that selectively concentrates at the inner mitochondrial membrane, where it binds cardiolipin and is studied for its effects on mitochondrial dysfunction in research models.

SS-31 has been studied in pre-clinical models of age-associated mitochondrial decline, cardiac ischemia- reperfusion injury, neurodegeneration, and inherited mitochondrial disease. The compound is also the only one in this category that has progressed through human clinical trials in a specific therapeutic context (albeit not for aging directly).

Research-grade SS-31 is available from the SS-31 product page.

MOTS-c: mitochondrially-encoded aging-biology

MOTS-c is unusual because it's a peptide encoded within the mitochondrial 12S ribosomal RNA gene rather than in the nucleus. It is one of the few characterised mitochondrially-derived peptides and has become a focal point of metabolic-aging research. Published studies have examined MOTS-c effects on AMPK pathway activation, glucose homeostasis, insulin sensitivity, mitochondrial biogenesis, and exercise capacity — all areas where age-related decline is well-documented.

The aging-research framing for MOTS-c rests on the observation that mitochondrially-derived peptide signalling contributes to metabolic flexibility, and that age-related decline in metabolic flexibility is a foundational aging mechanism. MOTS-c is studied as a putative regulator of this system. Research-grade MOTS-c is available from the MOTS-c product page.

GH-axis peptides and the somatopause hypothesis

The growth-hormone axis declines with age. Natural pulsatile GH release falls progressively from the third decade onward, and IGF-1 levels (the downstream output of GH signalling) follow. The age-related decline in GH-axis function has been called “somatopause” in aging-research literature — analogous to menopause and andropause but for the GH-IGF-1 axis specifically.

Research-grade GH-axis peptides — CJC-1295, Ipamorelin, Tesamorelin, and HGH itself — are studied in aging contexts as research tools for investigating whether partial restoration of GH-axis function affects age-related biomarkers. The published research is mixed: GH-axis restoration in older research populations has shown effects on body composition and IGF-1 markers, but the relationship to long-term aging endpoints is more contested.

The Quantum Labs Hormonal Support Protocol assembles CJC-1295 + Ipamorelin, Tesamorelin, and HGH for ageing-axis research designs. Full coverage of the GH peptide family is in our GH peptides research guide.

Glutathione: oxidative-stress and aging biology

Oxidative stress is another canonical aging hallmark, and glutathione is the most abundant endogenous intracellular antioxidant. Tissue glutathione levels decline with age in most published models, and the decline correlates with reduced cellular antioxidant capacity and increased oxidative damage markers.

For aging-research designs, glutathione functions as a support compound rather than a primary intervention. It maintains the cellular redox environment in which other aging-biology mechanisms operate. Research-grade glutathione is available from the Glutathione product page.

What “anti-aging” means in research vs in marketing

A note on language. “Anti-aging” in research literature means investigation of specific molecular and cellular mechanisms that change with age — telomerase activity, NAD+ levels, mitochondrial function, oxidative balance, etc. The research is rigorous and the mechanisms are characterised. What it doesn't mean is that any specific compound, taken by any specific individual, will reverse aging or extend lifespan. The translation from research-mechanism to individual-outcome is the long and contested path that the field is still working through.

In contrast, “anti-aging” in consumer cosmetic marketing usually refers to specific topical or appearance-focused claims aimed at specific consumer outcomes. This is a different category with different regulatory rules and different evidence standards.

Quantum Labs supplies research-grade compounds for aging-biology research, not for consumer anti-aging applications. The framing throughout our catalog is research and laboratory use only.

Putting together a longevity-research framework

For Australian researchers building an aging-biology research programme, the catalog of relevant compounds spans:

• Epithalon for telomerase / telomere research.
• NAD+ for cellular-energy and sirtuin-axis research.
• SS-31 for mitochondrial-targeted aging research.
• MOTS-c for mitochondrial-derived peptide signalling and metabolic-flexibility research.
• GHK-Cu for dermal-aging and broader regenerative pathways.
• CJC-1295 + Ipamorelin, Tesamorelin, HGH for GH-axis / somatopause research.
• Glutathione for oxidative-balance cellular biology.

The compounds aren't interchangeable — each targets different aging mechanisms — and combining them in research designs follows the same complementarity-not-redundancy principle that applies to research peptide stacks generally. For broader cycle and stack design context, see our peptide cycling 101 guide.

Regulatory framework for aging-research peptides

Most of the compounds discussed above are restricted for compounded human therapeutic supply in Australia but remain available for research and laboratory use without therapeutic representation. NAD+ and Glutathione have somewhat broader availability under research and supplementary-use pathways. HGH is a Schedule 4 prescription medicine. The full regulatory framework is covered in our peptide legality guide.

Quantum Labs supplies all aging-research peptides as research-grade material only, HPLC-verified to ≥99% purity, with batch-traceable certificates of analysis available on request. Research-supply pathway throughout.